JANE STREET GROUP, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 30 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$3,000
-78.6%
15,330
-48.1%
0.00%
Q2 2019$14,000
-41.7%
29,534
-62.5%
0.00%
Q4 2018$24,000
-41.5%
78,707
+38.5%
0.00%
Q3 2018$41,000
+115.8%
56,808
+26.0%
0.00%
Q2 2018$19,000
-5.0%
45,072
+24.2%
0.00%
Q1 2018$20,000
-20.0%
36,296
-4.1%
0.00%
Q4 2017$25,000
-3.8%
37,831
-15.7%
0.00%
Q3 2017$26,000
-54.4%
44,900
-34.4%
0.00%
Q2 2017$57,000
-77.6%
68,488
-63.4%
0.00%
-100.0%
Q1 2017$255,000
+47.4%
187,165
-51.7%
0.00%0.0%
Q4 2016$173,000
+2062.5%
387,763
+2712.3%
0.00%
Q3 2016$8,000
-11.1%
13,788
+1.3%
0.00%
Q2 2016$9,000
-72.7%
13,610
-64.8%
0.00%
Q1 2016$33,000
-77.1%
38,703
-72.7%
0.00%
-100.0%
Q4 2015$144,000
+193.9%
141,633
+241.2%
0.00%
Q3 2015$49,000
-79.3%
41,514
-65.9%
0.00%
-100.0%
Q2 2015$237,000
+777.8%
121,723
+714.0%
0.00%
Q1 2015$27,000
-70.3%
14,953
-69.7%
0.00%
-100.0%
Q4 2014$91,000
+11.0%
49,404
+45.1%
0.00%0.0%
Q3 2014$82,000
+54.7%
34,046
+135.9%
0.00%0.0%
Q2 2014$53,000
+8.2%
14,430
+34.1%
0.00%0.0%
Q1 2014$49,00010,7610.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,500,000$1,817,0000.46%
Fosun International Ltd 2,631,400$1,881,0000.09%
Zhang Financial LLC 45,000$34,0000.02%
SECTORAL ASSET MANAGEMENT INC 99,667$72,0000.01%
ETF MANAGERS GROUP, LLC 331,521$221,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,064$91,0000.00%
B. Riley Wealth Management, Inc. 18,329$13,0000.00%
Virtu Financial LLC 63,626$46,0000.00%
Renaissance Technologies 3,266,401$2,374,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 214,938$156,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders